Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

124 ARTÍCULOS , VIENDO DEL 76 AL 90

Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease

Guo X, Tang P, Liu P, Liu Y, Hou C, Li R.

J Neurol Sci. 2014 Nov 15;346(1-2):6-10. doi: 10.1016/j.jns.2014.07.064. Epub 2014 Aug 7.

Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials

Jia Q, Deng Y, Qing H.

Biomed Res Int. 2014;2014:837157. doi: 10.1155/2014/837157. Epub 2014 Jul 17.

Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan

Fouquet M, Besson FL, Gonneaud J, La Joie R, Chételat G.

Neuropsychol Rev. 2014 Sep;24(3):290-9. doi: 10.1007/s11065-014-9263-8. Epub 2014 Aug 22.

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L.

Alzheimers Dement. 2014 Nov;10(6):808-17. doi: 10.1016/j.jalz.2014.03.003. Epub 2014 Aug 20.

An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach

Cenini G, Fiorini A, Sultana R, Perluigi M, Cai J, Klein JB, Head E, Butterfield DA.

Free Radic Biol Med. 2014 Nov;76:89-95. doi: 10.1016/j.freeradbiomed.2014.08.006. Epub 2014 Aug 20.

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Babić M, Svob Štrac D, Mück-Šeler D, Pivac N, Stanić G, Hof PR, Simić G.

Croat Med J. 2014 Aug 28;55(4):347-65. doi: 10.3325/cmj.2014.55.347.

Early neuropsychological detection of Alzheimer's disease

Bastin C, Salmon E.

Eur J Clin Nutr. 2014 Nov;68(11):1192-9. doi: 10.1038/ejcn.2014.176. Epub 2014 Sep 3.

Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis

Willette AA, Calhoun VD, Egan JM, Kapogiannis D; Alzheimer׳s Disease Neuroimaging Initiative.

Psychiatry Res. 2014 Nov 30;224(2):81-8. doi: 10.1016/j.pscychresns.2014.08.005. Epub 2014 Aug 17.

3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease

Zou JX, Wang MJ, Lei XJ, Chen XG.

Exp Gerontol. 2014 Dec;60:31-6. doi: 10.1016/j.exger.2014.09.009. Epub 2014 Sep 16.

Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease

González-Domínguez R, García-Barrera T, Gómez-Ariza JL.

Anal Bioanal Chem. 2014 Nov;406(28):7137-48. doi: 10.1007/s00216-014-8102-3. Epub 2014 Sep 18.

There are no differences in IL-6, CRP and homocystein concentrations between women whose mothers had AD and women whose mothers did not have AD

Devčić S, Glamuzina L, Ruljancic N, Mihanovic M.

Psychiatry Res. 2014 Dec 30;220(3):970-4. doi: 10.1016/j.psychres.2014.08.059. Epub 2014 Sep 7.

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis

Stoeck K, Schmitz M, Ebert E, Schmidt C, Zerr I.

J Neuroinflammation. 2014 Oct 15;11:170. doi: 10.1186/s12974-014-0170-y.

Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin

Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, Tüscher O, Fellgiebel A.

Neurology. 2014 Nov 18;83(21):1930-5. doi: 10.1212/WNL.0000000000001017. Epub 2014 Oct 24.

Quantitative proteomics of delirium cerebrospinal fluid

Poljak A, Hill M, Hall RJ, MacLullich AM, Raftery MJ, Tai J, Yan S, Caplan GA.

Transl Psychiatry. 2014 Nov 4;4(11):e477. doi: 10.1038/tp.2014.114.

A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease

Rosenbloom MH, Barclay TR, Pyle M, Owens BL, Cagan AB, Anderson CP, Frey WH 2nd, Hanson LR.

CNS Drugs. 2014 Dec;28(12):1185-9. doi: 10.1007/s40263-014-0214-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias